Hamps Bio Ltd
HAMPSHamps Bio Ltd
HAMPS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹26 cr, stock is ranked 3,989
High RiskStock is 5.00x as volatile as Nifty
58.004.05% (-2.45)
58.004.05% (-2.45)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 7.81 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 48.65 | 6.19 | 0.55% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Hamps Bio Limited is an India-based company engaged in pharmaceutical formulation and freeze-drying ingredient manufacturing, offering home pharmaceutical products and freeze-dried food products.
Peers
Compare with peersSUNPHARMA
PE Ratio
42.59
1Y Return
10.39%
Buy Reco %
85.29
CIPLA
PE Ratio
28.47
1Y Return
1.01%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
63.47
1Y Return
16.81%
Buy Reco %
70.37
MANKIND
PE Ratio
52.85
1Y Return
9.56%
Buy Reco %
80.00
DRREDDY
PE Ratio
18.07
1Y Return
4.01%
Buy Reco %
40.63
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.34 | 5.59 | 6.51 | — | ||||
Raw Materials | 2.11 | 1.64 | 2.48 | — | ||||
| Power & Fuel Cost | 0.33 | 0.45 | 0.50 | |||||
| Employee Cost | 1.69 | 1.79 | 1.71 | |||||
| Selling & Administrative Expenses | 0.39 | 0.57 | 1.21 | |||||
| Operating & Other expenses | 0.21 | 0.26 | -0.61 | |||||
EBITDA | 0.61 | 0.88 | 1.22 | — | ||||
| Depreciation/Amortization | 0.33 | 0.34 | 0.40 | — | ||||
| PBIT | 0.28 | 0.54 | 0.82 | — | ||||
| Interest & Other Items | 0.19 | 0.18 | 0.15 | — | ||||
| PBT | 0.09 | 0.36 | 0.67 | — | ||||
| Taxes & Other Items | -0.02 | 0.00 | 0.15 | — | ||||
| Net Income | 0.11 | 0.36 | 0.52 | — | ||||
| EPS | 0.46 | 1.50 | 1.88 | — | ||||
| DPS | 0.00 | 0.00 | 0.00 | — | ||||
| Payout ratio | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Hamps Bio Ltd | 50.64 | 7.81 | — |
| Sun Pharmaceutical Industries Ltd | 42.59 | 6.08 | 0.79% |
| Cipla Ltd | 28.47 | 4.38 | 0.89% |
| Torrent Pharmaceuticals Ltd | 63.47 | 15.33 | 0.90% |
Price Comparison
Compare HAMPS with any stock or ETFCompare HAMPS with any stock or ETF
HAMPS
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Jul 2024
Dec 2024
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
HAMPS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Corporate
Hamps Bio to convene EGM
Hamps Bio announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Decreased Total Promoter Holding
In last 6 months, promoter holding in the company has decreased by 28.01%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant